NCT00024206View on ClinicalTrials.gov

SU6668 in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 31, 2001

Primary Completion Date

July 31, 2003

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

orantinib

Given orally

OTHER

laboratory biomarker analysis

Correlative studies

OTHER

pharmacological study

Correlative studies

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00024206 - SU6668 in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter